Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy is a research paper published in Nature Biotechnology (2024). On theSindex it has a DataRank of 0.732. It has been cited 131 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.732
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | National Institutes of Health
Grant: HL162564-02, R61AI161805
U.S. Department of Health & Human Services | National Institutes of Health
Grant: HL162564-02
U.S. Department of Health & Human Services | National Institutes of Health
Grant: HL152960, DK054759, 75N92019C00010
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: 5P30-CA14051
Sanofi
Grant: N/a
Cystic Fibrosis Foundation
Grant: WITTEN19XX0, 004831F5222
NHLBI NIH HHS
Grant: P01 HL152960
NCI NIH HHS
Grant: P30 CA014051
NHLBI NIH HHS
Grant: R01 HL162564
NIAID NIH HHS
Grant: R61 AI161805
NHLBI NIH HHS
Grant: 75N92019C00010
NIAID NIH HHS
Grant: R33 AI161805
NIDDK NIH HHS
Grant: P30 DK054759
NIEHS NIH HHS
Grant: P30 ES005605
National Institutes of Health
Grant: 1R61AI161805-01
Combinatorial and computational design of bnAb mRNA vaccines for HIV
National Institutes of Health
Grant: 5R01HL162564-03
Nonviral delivery techniques for in vivo prime editing
National Institutes of Health
Grant: 5P30CA014051-17
CELL BIOLOGY--DEVELOPMENTAL PROGRAM
National Institutes of Health
Grant: 5P01HL152960-02
Molecular Therapies for Cystic Fibrosis Lung Disease
Alpha-1 Foundation
FWCI
21.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals